Boundless Bio, Inc.
BOLD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $49,254 | $0 | $0 | $0 |
| - Cash | $26,587 | $23,706 | $10,951 | $34,289 |
| + Debt | $47,632 | $2,195 | $5,183 | $377 |
| Enterprise Value | $70,299 | -$21,511 | -$5,768 | -$33,912 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1,086 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$64,277 | -$53,839 | -$45,527 | -$24,619 |
| % Margin | – | – | – | – |
| Net Income | -$65,363 | -$49,434 | -$45,901 | -$25,210 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.85 | -2.22 | -2.06 | -1.13 |
| % Growth | -73.4% | -7.8% | -82.3% | – |
| Operating Cash Flow | -$60,841 | -$46,855 | -$39,596 | -$23,248 |
| Capital Expenditures | -$2,536 | -$633 | -$1,066 | -$2,034 |
| Free Cash Flow | -$63,377 | -$47,488 | -$40,662 | -$25,282 |